Position in CYTK
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$8,249,118
+$2,020,426 QoQ
Shares Held
96,832
+2.5% QoQ
Ownership
0.070%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#136
of 477 holders
Holding Since
Sep 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,105,781,868 across 230 Biotechnology names. CYTK ranks #90 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in CYTK
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,249,118 | 96,832 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $6,228,692 | 94,503 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $3,426,648 | 53,929 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,817,194 | 51,259 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,060,121 | 32,086 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,247,256 | 31,034 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $4,427,592 | 94,124 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $6,327,129 | 119,832 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $8,049,034 | 148,561 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $8,146,010 | 116,189 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $339,136 | 4,062 | Shares | Sole | 2024-02-07 | |
| 2023-06-30 | $754,370 | 23,126 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $799,059 | 22,707 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $837,085 | 18,269 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $959,697 | 19,808 | Shares | Sole | 2022-11-10 | |
| No filing history on record for this holder in this stock. | ||||||